Liquid biopsy mutation panel for non-small cell lung cancer: analytical validation and clinical concordance.

Schwartzberg, Lee S; Horinouchi, Hidehito; Chan, David; Chernilo, Sara; Tsai, Michaela L; Isla, Dolores; Escriu, Carles; Bennett, John P; Clark-Langone, Kim; Svedman, Christer; Tomasini, Pascale.

Afiliação

Schwartzberg LS; West Cancer Center & Research Institute, 7945 Wolf River Boulevard, Germantown, TN 38138 USA.
Horinouchi H; National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045 Japan.
Chan D; Cancer Care Associates TMPN (now Hunt Cancer Center), 3285 Skypark Dr, Torrance, CA 90505 USA.
Chernilo S; Instituto Nacional del Tórax, José Manuel Infante 717, segundo piso, Providencia, 7500691 Santiago, Chile.
Tsai ML; Virginia Piper Cancer Institute, Minnesota Oncology, 800 E 28th St., Suite 602, Minneapolis, MN 55407 USA.
Isla D; University Hospital Lozano Blesa, Avda. S. Juan Bosco no 15, 50009 Zaragoza, Spain.
Escriu C; The Clatterbridge Cancer Centre, Clatterbridge Road, Bebington, Wirral, CH63 4JK UK.
Bennett JP; Genomic Health, Inc. (now Exact Sciences Corp.), 301 Penobscot Dr, Redwood City, CA 94063 USA.
Clark-Langone K; Genomic Health, Inc. (now Exact Sciences Corp.), 301 Penobscot Dr, Redwood City, CA 94063 USA.
Svedman C; Genomic Health, Inc. (now Exact Sciences Corp.), 301 Penobscot Dr, Redwood City, CA 94063 USA.
Tomasini P; Assistance Publique Hôpitaux de Marseille, and Centre de Recherche en Cancérologie de Marseille, Inserm UMR1068, CNRS UMR7258, Aix-Marseille Université, UM105 Marseille, France.